Company Filing History:
Years Active: 2011
Title: Jorn Erland Koch: Innovator in Oligonucleotide Production
Introduction
Jorn Erland Koch is a notable inventor based in Ry, Denmark. He has made significant contributions to the field of oligonucleotide production, holding 2 patents that showcase his innovative approaches. His work focuses on enhancing the efficiency and effectiveness of oligonucleotide synthesis and detection.
Latest Patents
Koch's latest patents include methods for the production of oligonucleotides using rolling circle replication. This invention allows for the synthesis of multimeric oligonucleotides, which can be reduced to mononucleotides using a nicking cassette. This method enables efficient amplification of oligonucleotides up to lengths of at least 1000 nucleotides, providing high yields contained within a nicking cassette. Another significant patent involves circle probes and their use in the identification of biomolecules. This invention provides oligonucleotides and methods for the efficient detection of target nucleic acids, allowing for circularization without an external ligation template. The oligonucleotides can generate a free 3' end of the target nucleic acid necessary for rolling circle replication, making them useful as research tools and for diagnostic purposes.
Career Highlights
Throughout his career, Jorn Erland Koch has worked with several companies, including In Situ Rcp A/S and Olink AB. His experience in these organizations has contributed to his expertise in the field of biotechnology and oligonucleotide research.
Collaborations
Koch has collaborated with notable colleagues such as Magnus Stougaard and Jakob Schwalbe Lohmann. These partnerships have likely enriched his research and development efforts in oligonucleotide technologies.
Conclusion
Jorn Erland Koch is a prominent figure in the field of oligonucleotide production, with innovative patents that enhance the efficiency of synthesis and detection methods. His contributions continue to impact research and diagnostics in biotechnology.